跳至主要内容
临床试验/NCT01569594
NCT01569594已完成不适用

CorMatrix® ECM® for Carotid Repair Following Endarterectomy Registry

Aziyo Biologics, Inc.6 个研究点 分布在 1 个国家目标入组 230 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
230
试验地点
6
主要终点
Carotid Procedure and Device Related Adverse Events to Determine Device Performance

研究概览

简要总结

Assess device performance data from subjects undergoing patch angioplasty of the carotid artery following carotid endarterectomy using the CorMatrix ECM for Carotid Repair.

详细描述

The objective of this registry is to capture and assess device performance data from subjects undergoing patch angioplasty of the carotid artery following carotid endarterectomy using the CorMatrix ECM for Carotid Repair per its FDA cleared Indications for Use. This registry provides an ongoing post-market surveillance mechanism to document clinical outcomes on the use of the CorMatrix ECM for Carotid Repair.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subjects must be undergoing carotid endarterectomy with patch angioplasty closure.
  • Subject's operative surgeon intends to use CorMatrix ECM as the patch material for closure of the carotid artery per its FDA cleared Indications for Use.
  • The subject must possess the ability to provide written Informed Consent.
  • The subject must express an understanding and willingness to fulfill all of the expected requirements of this clinical protocol.

排除标准

  • Subjects with a known sensitivity to porcine material.

结局指标

主要结局

Carotid Procedure and Device Related Adverse Events to Determine Device Performance

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

CorMatrix ECM for Carotid Repair Following... | 临床试验